How should severe migraine and tinnitus that occur during a deep transcranial magnetic stimulation (deep TMS) session be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Severe Migraine and Tinnitus During Deep TMS

Immediately discontinue the deep TMS session if severe migraine and tinnitus occur, then treat the acute migraine with migraine-specific agents (triptans) or parenteral NSAIDs like ketorolac, while recognizing that tinnitus is a known adverse effect of transcranial stimulation that typically resolves after stopping treatment.

Immediate Action During the Session

When severe migraine and tinnitus develop during deep TMS:

  • Stop the stimulation immediately - Both headache and tinnitus are recognized adverse effects of transcranial magnetic stimulation 1
  • Do not continue or complete the planned session
  • Monitor the patient for symptom evolution over the next 15-30 minutes

Acute Migraine Management

First-Line Treatment for Severe Migraine

For severe migraine that occurs during TMS, use migraine-specific agents rather than simple analgesics 2, 3:

  • Triptans (sumatriptan, rizatriptan, zolmitriptan, naratriptan) - most effective when given early 3

    • Subcutaneous sumatriptan provides fastest relief for rapidly escalating severe migraine 2
    • Oral triptans if nausea/vomiting not prominent
  • Parenteral ketorolac (Toradol) 60 mg IM - specifically reserved for severe migraines with rapid onset and 6-hour duration 2

    • Advantage: rebound headache unlikely compared to other analgesics
    • Maximum 120 mg/day, treatment not to exceed 5 days

Alternative Options

If triptans contraindicated or unavailable 2:

  • Combination therapy: aspirin 650-1000 mg + acetaminophen + caffeine
  • Dihydroergotamine (DHE) nasal spray
  • Opioid analgesics (meperidine 50-150 mg IM/IV or butorphanol nasal spray) only as rescue medication when other treatments fail

Adjunctive Treatment

  • Antiemetics if nausea present: metoclopramide or prochlorperazine 2
  • Consider non-oral routes if significant nausea/vomiting 2

Managing the Tinnitus Component

The tinnitus occurring during TMS is typically transient and resolves after discontinuation 1:

  • Tinnitus during transcranial stimulation is reported in up to 30-70% of sessions as a mild adverse effect 1
  • No specific medical therapy is recommended for acute TMS-related tinnitus 4
  • Avoid antidepressants, anticonvulsants, or anxiolytics specifically for the tinnitus - these are not routinely recommended and lack evidence 4
  • Do not use dietary supplements (Ginkgo biloba, melatonin, zinc) - these have no proven efficacy 4

Critical Clinical Considerations

Reassess TMS Candidacy

This patient may not be an appropriate candidate for continued deep TMS treatment 5, 6:

  • While deep TMS can treat chronic migraine 5, severe migraine occurring during treatment suggests the patient is experiencing adverse effects rather than therapeutic benefit
  • The combination of severe migraine + tinnitus during stimulation indicates significant cortical reactivity
  • Consider whether the patient has underlying migraine that makes them more susceptible to TMS-related headache 1

Important Pitfalls to Avoid

  1. Do not continue TMS hoping symptoms will resolve - this risks worsening both migraine and tinnitus
  2. Do not use acetaminophen alone - it is ineffective for migraine 2
  3. Avoid opioids as first-line - reserve only for rescue when other treatments fail, due to dependency and rebound headache risks 2
  4. Do not overuse acute medications - limit to twice weekly to prevent medication overuse headache 7

Documentation and Follow-up

Document this adverse event carefully:

  • Timing of symptom onset relative to TMS parameters (frequency, intensity, duration into session)
  • Severity and characteristics of both migraine and tinnitus
  • Response to acute treatment
  • Time to complete resolution

Before considering any future TMS sessions, ensure:

  • Complete resolution of symptoms
  • Neurologic examination is normal
  • Discussion of risks vs. benefits with patient
  • Consider alternative treatments for the underlying condition being treated with TMS

Connection Between Migraine and Tinnitus

Recognize that migraine and tinnitus are pathophysiologically linked 8, 9, 10:

  • Patients with migraine have higher rates of tinnitus
  • Tinnitus often exacerbates during migraine attacks in 45% of patients with both conditions 9
  • This connection may explain why both symptoms emerged simultaneously during TMS

The occurrence of both symptoms during deep TMS likely represents a shared mechanism of cortical hyperexcitability triggered by the magnetic stimulation.

References

Guideline

management of the acute migraine headache.

American family physician, 2002

Guideline

diagnosis and management of migraine in ten steps.

Nature Reviews Neurology, 2021

Guideline

clinical practice guideline: tinnitus executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014

Research

Impact of Migraine on the Tinnitus-Specific Health-Related Quality of Life and Psychiatric Comorbidities in Patients with Tinnitus.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2024

Research

Impact of Migraine and Vestibular Migraine on Audiometric Profiles and Quality of Life in Patients With Tinnitus.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2024

Related Questions

Is deep transcranial magnetic stimulation (deep TMS) contraindicated in patients with recurrent headaches?
Is migraine a contraindication for deep transcranial magnetic stimulation (deep TMS)?
Can a patient with migraine managed with triptans and stellate ganglion blocks undergo deep transcranial magnetic stimulation (DTMS) for major depressive disorder?
How should I manage a patient with worsening persistent tinnitus, occasional migraines, and vertigo in primary care?
How long does the seizure‑aborting effect of a 5 mg Valtoco (diazepam) nasal spray dose last when administered to each nostril?
What is the appropriate SOAP note, including CPT code 99213 and ICD‑10 codes, for an 87‑year‑old female presenting to clinic after an emergency department visit for urinary tract infection symptoms, who was prescribed nitrofurantoin (Macrobid) 100 mg twice daily, has a culture susceptible to nitrofurantoin, a normal urinalysis today, a history of hypertension, major depressive disorder, and peripheral neuropathy pain, and has one day of nitrofurantoin remaining with no further antibiotics to be prescribed?
In an otherwise well adult with a normal examination, what is the significance of a low creatine phosphokinase level, low platelet count, and elevated D‑dimer, and what evaluation and management are recommended?
Can a patient with migraine managed with triptans and stellate ganglion blocks undergo deep transcranial magnetic stimulation (DTMS) for major depressive disorder?
What is the appropriate adult dosing regimen for amikacin injection, including renal function adjustments?
What does a diagonal earlobe crease (Frank's sign) indicate about cardiovascular risk, and what evaluation and preventive measures should be recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.